metricas
covid
Buscar en
Neurología (English Edition)
Toda la web
Inicio Neurología (English Edition) Cryptogenic stroke in young patients: Long-term prognosis and recurrence
Información de la revista
Vol. 26. Núm. 5.
Páginas 279-284 (enero 2010)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 26. Núm. 5.
Páginas 279-284 (enero 2010)
Acceso a texto completo
Cryptogenic stroke in young patients: Long-term prognosis and recurrence
Infarto cerebral criptogénico en pacientes jóvenes. Pronóstico y recurrencia a largo plazo
Visitas
1375
A. Arauza,
Autor para correspondencia
, M. Merlos-Beníteza, L.F. Roaa, B. Hernández-Curiela, C. Cantúb, L. Murilloc, J. Roldánd, J. Vargas-Barrónd, F. Barinagarrementeriae
a Clínica de Enfermedad Vascular Cerebral, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, México City, Mexico
b Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico
c Facultad de Medicina, Universidad Autónoma de Guadalajara, Guadalajara, Mexico
d Departamento de Ecocardiografía, Instituto Nacional de Cardiología Ignacio Chávez, México City, Mexico
e Facultad de Medicina, Universidad del Valle de México, Querétaro, Mexico
Este artículo ha recibido
Información del artículo
Abstract
Background

Around 40% of strokes in young people are labelled as infarcts of undetermined cause. The aim of this study was to determine the image characteristics, the long-term functional outcome and recurrence after cryptogenic ischaemic stroke.

Methods

We studied ninety-eight patients under 45 years of age during a median follow up of 54 months (range 12–238), with ischaemic stroke of undetermined cause. We registered vascular risk factors, clinical syndrome, laboratory and imaging results. We used Rankin disability score to assess functional outcome. The cases were evaluated with intracranial and extracranial vascular imaging studies, echocardiogram, and at least two determinations of prothrombotic states.

Results

In our hospital 11% of the patients with cerebral infarction under 45 years of age were labelled as cryptogenic. The mean age of the cases was 39.5±5, 48 (49%) were women, 6 (6%) had arterial hypertension, 7 (7%) prior history of migraine, 32 (33%) were active smokers, 11 (11%) had hypercholesterolemia, and 11 (11%) had alcoholism. All cases were treated with aspirin. We observed good functional outcome (Rankin 0–2) in 65 (65%) cases. The anterior circulation was the most affected (partial in 56%, total in 12%). Infarction was unique in 87 (88%) cases. Recurrence was observed in 4 (4%) cases.

Conclusions

In this study cryptogenic cerebral infarctions were mostly single, had low recurrence and good functional outcome in the long-term follow-up. Total anterior circulation infarctions correlated with poor outcome.

Keywords:
Cryptogenic infarct
Recurrence
Outcome
Resumen
Antecedentes

En menores de 45 años, el infarto cerebral (IC) criptogénico representa hasta el 40% de los casos. El objetivo de la presente serie es determinar la tasa de recurrencia, la evolución clínica funcional a largo plazo y las características de imagen de pacientes menores de 45 años, con IC criptogénico.

Métodos

98 pacientes con diagnóstico confirmado de IC criptogénico fueron seguidos durante una mediana de 54 meses (rango de 12 a 238). Registramos los datos demográficos, factores de riesgo, hallazgos clínicos, de laboratorio y de imagen, así como las complicaciones y la evolución funcional. La evaluación de los casos incluyó estudios de imagen vascular intra y extracraneal, ecocardiograma y dos determinaciones de estudios protrombóticos.

Resultados

Esta serie representa el 11% de los casos de IC en jóvenes en nuestro hospital. La edad promedio de los casos fue de 39,5±5, 48 (49%) fueron mujeres, 6 (6%) tenían hipertensión arterial, 11 (11%) hipercolesterolemia, 7 (7%) antecedente de migraña, 32 (33%) de tabaquismo activo y 11 (11%) de alcoholismo. Todos los casos fueron manejados con aspirina. Se observó buen pronóstico funcional (Rankin 0 a 2) en 65 (66%) casos y recurrencia en 4 (4%). La circulación anterior (parcial en 56%, total 12%) fue la más afectada y en 87 (88%) casos el infarto fue único.

Conclusiones

En esta serie, los IC criptogénicos fueron mayoritariamente únicos, con baja recurrencia y buen pronóstico funcional a largo plazo. Los infartos totales de circulación anterior se correlacionaron con mal pronóstico.

Palabras clave:
Infarto cerebral en joven
Pronóstico
Recurrencia
El Texto completo está disponible en PDF
References
[1.]
R. Sacco, J. Ellenberg, J. Mohr, T. Tatemichi, D. Hier, T. Price, P. Wolf.
Infarcts of undetermined cause: The NINCDS Stroke Data Bank.
Ann Neurol, 25 (1989), pp. 382-390
[2.]
F. Barinagarrementerria, A. González, C. Cantú.
Estados protrombóticos e isquemia cerebral.
Rev Neurol, 26 (1998), pp. 85-91
[3.]
O. Bang, P. Lee, S. Joo, J. Lee, I. Joo, K. Huh.
Frequency and mechanisms of stroke recurrence after cryptogenic stroke.
Ann Neurol, 54 (2003), pp. 227-234
[4.]
U. Waje-Andreassen, H. Naess, L. Thomassen, G. Eide, C. Vedeler.
Arterial Events after Ischemic Stroke at a Young Age: A Cross-Sectional Long-Term Follow-Up of Patients and Controls in Western Norway.
Cerebrovasc Dis, 24 (2007), pp. 277-282
[5.]
J. Putaala, A. Metso, T. Metso, N. Konkola, Y. Kraemer, E. Haapaniemi, et al.
Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: The Helsinki Young Stroke Registry.
Stroke, 40 (2009), pp. 1195-1203
[6.]
J. Rodés-Cabau, M. Noël, A. Marrero, D. Rivest, A. Mackey, C. Houde, et al.
Atherosclerotic burden findings in young cryptogenic stroke patients with and without a patent foramen ovale.
[7.]
F. Knebel, F. Masuhr, W. Von Hausen, T. Walde, H. Dreger, V. Raab, et al.
Transesophageal echocardiography in patients with cryptogenic cerebral ischemia.
Cardiovascular Ultrasound, 07 (2009), pp. 15-22
[8.]
H. Adams, B. Bendixen, L. Kappelle, J. Biller, B. Love, D. Gordon, et al.
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
Stroke, 24 (1993), pp. 35-41
[9.]
J. Kizer.
Evaluation of the patient with unexplained stroke.
Coron Artery Dis, 19 (2008), pp. 535-540
[10.]
J. Bamford, P. Sandercock, M. Dennis, J. Burn, C. Warlow.
Classification and natural history of clinically identifiable subtypes of cerebral infarction.
Lancet, 337 (1991), pp. 1521-1526
[11.]
R. Attaran, I. Ata, V. Kudithipudi, L. Foster, V. Sorrel.
Protocol for optimal detection and exclusion of a patent foramen ovale using transthoracic echocardiography with agitated saline microbubbles.
Echocardiography, 23 (2006), pp. 616-622
[12.]
J. Mas, M. Zuber.
Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French a study group on patent foramen ovale and atrial septal aneurysm.
Am Heart J, 130 (1995), pp. 1083-1088
[13.]
R. Sacco, R. Adams, G. Albers, M. Alberts, O. Benavente, K. Furie, et al.
Guidelines for Prevention of Stroke in Patients with Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association Council on Stroke.
Circulation, 113 (2006), pp. e409-e449
[14.]
R. De Haan, M. Limburg, P. Bossuyt, J. Van der Meulen, N. Aaronson.
The clinical meaning of Rankin “handicap” grades after stroke.
Stroke, 26 (1995), pp. 2027-2030
[15.]
F. Barinagarrementeria, T. Figueroa, J. Huebe, C. Cantú.
Cerebral infarction in people under 40 years etiologic analysis of 300 cases prospectively evaluated.
Cerebrovasc Dis, 6 (1996), pp. 75-79
[16.]
S. Kittner, B. Stern, M. Wozniak, D. Buchholz, C. Earley, B. Feeser, et al.
Cerebral infarction in young adults. The Baltimore-Washington Cooperative Young Stroke Study.
Neurology, 50 (1998), pp. 890-894
[17.]
M. Otero, C. Barbagelata.
Subtipos etiológicos de accidente cerebrovascular isquémico en adultos entre 18 y 45 años: Estudio de una serie de 93 pacientes.
Rev Clin Esp, 207 (2007), pp. 158-165
[18.]
G. Petty, R. Brown, J. Whisnant, J. Sicks, O’Fallon, D. Wiebers.
Ischemic stroke subtypes: A population-based study of functional outcome, survival, and recurrence.
Stroke, 31 (2000), pp. 1062-1068
[19.]
B. Voetsch, B.P. Damasceno, E.C. Camargo, A. Massaro, L.A. Bacheschi, M. Scaff, et al.
Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults.
Thromb Haemost, 83 (2000), pp. 229-233
[20.]
J. Casas, A. Hingorani, L. Baustista, P. Sharma.
Meta-analysis of genetic studies in ischemic stroke thirty-two genes involving approximately 18,000 cases and 58,000 controls.
Arch Neurol, 61 (2004), pp. 1652-1661
[21.]
M.A. Almekhlafi, S.B. Wilton, D.M. Rabi, W.A. Ghali, D.K. Lorenzetti, M.D. Hill.
Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis.
[22.]
F. Guercini, M. Acciarresi, G. Agnelli, M. Paciaroni.
Cryptogenic stroke: time to determine aetiology.
J Thromb Haemost, 6 (2008), pp. 549-554
[23.]
K. Todo, H. Moriwaki, K. Saito, H. Naritomi.
Frequent Premature atrial contractions in stroke of undetermined etiology.
Eur Neurol, 61 (2009), pp. 285-288
[24.]
M. Hillbom, H. Numminem, S. Juvela.
Recent heavy drinking of alcohol and embolic stroke.
Stroke, 30 (1999), pp. 2307-2312
[25.]
C. Lamy, C. Giannesini, M. Zuber, C. Arquizan, J. Meder, D. Trystram, et al.
Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: The PFO-ASA Study.
Stroke, 33 (2002), pp. 706-711
[26.]
C. Arming, A. Schrattenholzer, L. Lachenmayer.
Cervical carotid artery vasospasm causing cerebral ischemia.
Stroke, 29 (1998), pp. 1063-1066
[27.]
Ionita C, Siddiqui A, Levy E, Hopkins L, Snyder K, Gibbons K. Acute ischemic stroke and infections. J Stroke Cerebrovasc Dis. 2010. En prensa.
[28.]
A. Eggers.
A new theory of cryptogenic stroke and its relationship to patent foramen ovale; or, the puzzle of the missing extra risk.
Medical Hypotheses, 67 (2006), pp. 1072-1075
Copyright © 2011. Sociedad Española de Neurología
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos